View Solutions

Displaying 1 - 45 of 45
2017

CRISP is a comparative in silico structural/functional platform that offers potential for identifying species differences in liver activity. It enables users to screen a candidate compound against proteins...

2017

Nociceptive threshold testing (NTT) is widely used for testing sensory and nociceptive thresholds in pain research. von Frey filaments and hotplate technologies have been the standard methods for...

2017

Traditional antibodies are widely used in industry and academia but require the use of animals in their production and are estimated to waste up to $800 million/year due to inaccurate results. There is an...

2017

Sirius Scissor is the first analytical instrument that successfully mimics the subcutaneous environment of the human body, in vitro, regarding its physical, chemical, and physiological parameters. It...

2017

OcuScience has developed new methods to preserve human retinas from organ donors and make them viable for research for hours after death. We are able to revive and maintain the neural retina from adult...

2016

Researchers from the University of Turin, Italy are seeking partners to help further develop and validate innovative spinal cord slice platforms (SCSPs) for studying nociception and neuroinflammation ex...

2016

Researchers at the University of Dundee are seeking partners to assess the utility of their in vivo imaging methodology in a variety of applications. 

2016

Immundnz is seeking partnerships with companies to help validate COMPIT, an in vitro platform that enables the comprehensive analysis and prediction of the human immune response to drug molecules.

2016

Researchers from the Barts Cancer Institute, Queen Mary University of London are seeking partners to help further develop and validate Experimental Cancer Medicine Platforms (ECMPs) for studying cancer...

2016

Researchers from the University of Sheffield are seeking partners to help further develop, validate and commercialise a cell-based VAMP-reporter assay for tetanus toxoid testing. The approach has the...

2016

Stemina Biomarker Discovery, Inc. is seeking partners to help expand the use of devTOX; their human stem cell-based developmental toxicity screening assays. 

2016

Researchers from the University of Hull are seeking partners to explore the application of their microfluidic devices in reducing the use of animals for efficacy and safety testing of drugs and other...

2016

Biosystems Technology Ltd. is seeking partners interested in integrating their TruLarv™ Galleria mellonella assays into drug and chemical discovery platforms for early stage toxicity and efficacy screening...

2016

Researchers from the University of York are seeking partners with expertise in mammalian cell culture to develop novel approaches for in vitro-in vivo toxicity extrapolation to reduce the use of animals in...

2015

Lena Biosciences is seeking collaborators to validate, manufacture and commercialise their 3D cell culture perfusion platform which enables testing of slow-clearing biologicals, small molecule drugs and...

2015

Phenotox Ltd is seeking partners to help develop and test a novel mass-spectrometry-based profiling method that can detect the binding of label-free (unmodified) chemicals to potentially thousands of...

2015

Somark Innovations is seeking partners to adopt and evaluate their Labstamp mouse identification system. Labstamp is a more refined permanent method of identification; offering the lowest rate of...

2015

Data Sciences International is seeking partners to adopt their implantable telemetry device capable of providing continuous, real-time measurements of blood glucose, temperature, and activity in rats to...

2015

Avacta Life Sciences are seeking partners to help in the validation and development of Affimers. These animal-free alternatives to antibodies can be developed in less than 7 weeks against almost any target...

2015

Researchers from University of Freiburg, Germany, are seeking partners to validate and commercialize their novel automated bioluminescence assay (BLB-Test) for detecting botulinum neurotoxin (BoNT) to...

2015

GentleSharp, Inc., is seeking partners to help develop and expand the use of their GentleSharp low volume blood sampling technology.

2015

ETT S.p.A. is seeking agrochemical, pharmaceutical and chemical company collaborators to help validate our integrated approach for assessing neurotoxicity in vitro.

2015

Primetech is seeking partners to help expand the use of their novel microinfusion pumps for programmable infusion of test compounds in rats.

2014

Actual Analytics is seeking partners to help validate and extend the scope of their innovative home cage analysis system, which provides 24/7 monitoring of rodent behaviours in a group-housed environment...

2014

Aptasol are seeking partners interested in adopting or helping to develop their aptamers to replace the use of traditional animal-derived antibodies.

2014

Physiomics plc is seeking partners to help calibrate their new in silico model for optimising drug treatment regimens in clinical cancer studies.

2014

ZeClinics is seeking partners to help develop and validate a preclinical zebrafish embryo screen capable of identifying compounds with potential cardiac, hepato- and neurotoxicity liabilities in the same...

2014

EBERS is seeking partners to help create physiologically and pharmacologically relevant microfluidic 3D culture models to improve basic research and drug development, and reduce animal use.

2014

In Ovo is seeking partners to validate its new chick egg assay to assess efficacy and toxicity of anticancer drugs without using animals.

2014

Ostara Biomedical Ltd. is seeking partners to help developand validate a novel approach to reduce animals in transgenic breeding programmes.

 

2014

Professor Andrew Nelson (University of Leeds) is seeking partners to help develop and validate an approach to screen compounds, polymers and nanoparticles for potential biomembrane toxicity.

2013

Midas Mediscience Ltd. is seeking collaborators to help extend the utility of DrugPrint®, a novel model for predictive ion channel profiling and cardiotoxicity screening.

2013

Medicyte is seeking partners to help further develop and validate an in vitro human hepatocyte micronucleus (MN) assay for the prediction of genotoxicity in early drug development.

2013

Professor Susan Barnett (University of Glasgow) is seeking partners to help further develop and validate an in vitro model of spinal cord injury (SCI).

2013

Lein Applied Diagnostics is seeking partners to utilise a novel technology for making non-invasive pharmacokinetics (PK) measurements both in vivo and in vitro.

2013

Dr Tamer Mohammed (University of Manchester) is seeking partners to help develop and validate a human stem cell-based model for assessing the teratogenic potential of drugs and chemicals.

2012

Dr Alex Easton (Durham University) is seeking partners to help develop and validate a new apparatus to reduce animals used in studies of memory and cognition.

2012

Dr Tamer Mohamed (University of Manchester) is seeking partners to validate a human stem cell model as a standard approach of screening for cardiotoxicity.

2012

Professor Robin Williams (Royal Holloway, University of London) is seeking a partner(s) to validate a Dictyostelium model for identifying compounds with nausea and/or vomiting side effects.

2012

Kirkstall Ltd. is looking for partners to help develop better models of in vitro cell culture for studies of drug and chemical toxicity, disease, DMPK and stem cell differentiation. 

2012

Dr Rodolfo Gonella Diaza (Istituto di Ricerche Farmacologiche Mario Negri, Italy) is looking for partners to adopt his QSAR model for toxicity testing.

2012

FibromEd Ltd is keen to develop partnerships to develop and validate its HepatoinformTM platform for assessing hepatotoxicity. 

2012

Dr Colin Brown (Newcastle University and Abcellute) is looking for collaborators to develop and validate primary cell cultures for renal toxicity testing. 

2012

KIYATEC Inc. is seeking active collaborators from the pharmaceutical or biotechnology sector for co-development of novel 3D cell-based assays and models. 

2012

Brainwave-Discovery Ltd. is looking for a collaboration with a pharmaceutical company to develop and validate new models of neurodegenerative disease for target validation and compound screening.